Search

everythinglearnresearchcommunity

for

Search:↓

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Caloric stress and differentiation increase IRES translation, affecting stem cell function and potential therapies.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

New inhibitors may reduce gut toxicity from cancer drugs.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

EGFR inhibitors for lung cancer can cause severe skin issues.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

Ethosomes can safely and effectively deliver various drugs deep into the skin.

Nanotechnology in skincare can precisely deliver anti-aging genes to improve skin health.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Exosome therapy shows promise for hair loss but needs more research on safety and effectiveness.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Using existing drugs for new treatments is cost-effective and safer.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

A biomarker-guided approach can improve alopecia treatment by targeting specific pathways.

Targeted immunotherapy could be a promising new treatment for hair regrowth.